NCT02672423View on ClinicalTrials.gov

A Study of Abemaciclib in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

127

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions
Healthy
Interventions
DRUG

Abemaciclib Capsules (Reference Formulation)

Administered orally

DRUG

Abemaciclib Tablet (Test Formulation)

Administered orally

Trial Locations (2)

32117

Daytona Beach Clinical Research Unit, Daytona Beach

47710

Evansville Clinical Research Unit, Evansville

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT02672423 - A Study of Abemaciclib in Healthy Participants | Biotech Hunter | Biotech Hunter